Tc-99m pertechnetate
Citation, DOI, disclosures and article data
At the time the article was created The Radswiki had no recorded disclosures.
View The Radswiki's current disclosuresAt the time the article was last revised Sonam Vadera had no financial relationships to ineligible companies to disclose.
View Sonam Vadera's current disclosures- Technetium-99m pertechnetate
- Technetium-99 metastable pertechnetate
Tc-99m pertechnetate (Na+ 99mTc O4-) is one of the technetium radiopharmaceuticals used in imaging of thyroid, colon, bladder and stomach.
Technetium (99mTc) has eight oxidation states 6, from -1 to +7; specifically, the oxidation state of technetium in the pertechnetate anion (99mTcO4-) is +7. The pertechnetate anion is, among the chemical species of technetium, the most stable in aqueous solution 6,7.
On this page:
Characteristics
photon energy: 140 keV
protons: 43 (i.e. atomic number)
physical half-life: 6 hours
biological half-life: ~1 day
4.0 < pH < 8.0 6,7
radiochemical purity: >95%
molecular geometry (pertechnetate anion): tetrahedral 6,7
normal distribution: stomach, thyroid, salivary glands, testes
excretion: renal, GI
target organs: thyroid, colon, bladder, stomach, testicular (rarely performed)
compounding of technetium radiopharmaceuticals using technetium pertechnetate may be done under room temperature or heating 9
Uses, doses and timings
Pediatric doses have been derived from various sources; a true international consensus remains a work in progress.
-
adult dose: 370 MBq (10 mCi) IV
-
pediatric dose: 1.85 MBq/kg (0.05 mCi/kg) 5
minimum 9.25 MBq (0.25 mCi) 5
time of imaging: immediate (1 frame/s x 60 s then q 5-10 min x 1 hr)
-
adult dose: 37-74 MBq (1-2 mCi) IV
time of imaging: image for 15 minutes after Tl-201 injection and imaging
-
adult dose: 370 MBq (10 mCi) IV
-
pediatric dose: pending mCi/kg
minimum 185 MBq (5 mCi) 3
time of imaging: 60 second flow study with delayed static images
-
-
adult dose: 37-370 MBq (1-10 mCi) IV
usually 111-185 MBq (3-5 mCi)
time of imaging: 20 minutes
-
History and etymology
Technetium was discovered in 1937 by C Perrier and Emilio Segre at Palermo University. They managed to isolate technetium-97 from a sample of molybdenum irradiated with deuterons in the cyclotron of the University of Berkeley 8.
See also
Quiz questions
References
- 1. Pecora DV, Sagar V, Piccone J. Technetium-99m pertechnetate as an indicator of gastric mucosal proliferation. AJR Am J Roentgenol. 1978;131 (6): 1041-2. AJR Am J Roentgenol (abstract) - Pubmed citation
- 2. Pfestroff A, Müller F, Librizzi D et-al. Scintigraphic assessment of salivary gland function in a rat model. In Vivo. 24 (5): 681-5. In Vivo (abstract) - Pubmed citation
- 3. MacDonald A, Burrell S. Infrequently performed studies in nuclear medicine: part 2. (2009) Journal of nuclear medicine technology. 37 (1): 1-13. doi:10.2967/jnmt.108.057851 - Pubmed
- 4. MacDonald A, Burrell S. Infrequently performed studies in nuclear medicine: Part 1. (2008) Journal of nuclear medicine technology. 36 (3): 132-43; quiz 145. doi:10.2967/jnmt.108.051383 - Pubmed
- 5. Gelfand MJ, Parisi MT, Treves ST. Pediatric radiopharmaceutical administered doses: 2010 North American consensus guidelines. (2011) Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 52 (2): 318-22. doi:10.2967/jnumed.110.084327 - Pubmed
- 6. M. P. Natale. P&C 5.1. Tecnico di radiologia. Guida completa alla preparazione di test preselettivi e prove pratiche per TSRM. Con software di simulazione. (2019) ISBN: 9788865846483
- 7. Maurizio Dondi, Raffaele Giubbini. Medicina nucleare nella pratica clinica. Con CD-ROM. (2019) ISBN: 9788855527286
- 8. de Jonge FA, Pauwels EK. Technetium, the missing element. (1996) European journal of nuclear medicine. 23 (3): 336-44. doi:10.1007/bf00837634 - Pubmed
- 9. Technical reports series, No 466. Technetium-99m Radiopharmaceuticals: Manufacture of Kits. 2008. ISBN: 978-92-0-100408-6. International Atomic Energy Agency
Incoming Links
Related articles: Imaging technology
- imaging technology
- imaging physics
- imaging in practice
-
x-rays
- x-ray physics
- x-ray in practice
- x-ray production
- x-ray tube
- filters
- automatic exposure control (AEC)
- beam collimators
- grids
- air gap technique
- cassette
- intensifying screen
- x-ray film
- image intensifier
- digital radiography
- digital image
- mammography
- x-ray artifacts
- radiation units
- radiation safety
- radiation detectors
- fluoroscopy
-
computed tomography (CT)
- CT physics
- CT in practice
- CT technology
- CT image reconstruction
- CT image quality
- CT dose
-
CT contrast media
-
iodinated contrast media
- agents
- water soluble
- water insoluble
- vicarious contrast material excretion
- iodinated contrast media adverse reactions
- agents
- non-iodinated contrast media
-
iodinated contrast media
-
CT artifacts
- patient-based artifacts
- physics-based artifacts
- hardware-based artifacts
- ring artifact
- tube arcing
- out of field artifact
- air bubble artifact
- helical and multichannel artifacts
- CT safety
- history of CT
-
MRI
- MRI physics
- MRI in practice
- MRI hardware
- signal processing
-
MRI pulse sequences (basics | abbreviations | parameters)
- T1 weighted image
- T2 weighted image
- proton density weighted image
- chemical exchange saturation transfer
- CSF flow studies
- diffusion weighted imaging (DWI)
- echo-planar pulse sequences
- fat-suppressed imaging sequences
- gradient echo sequences
- inversion recovery sequences
- metal artifact reduction sequence (MARS)
-
perfusion-weighted imaging
- techniques
- derived values
- saturation recovery sequences
- spin echo sequences
- spiral pulse sequences
- susceptibility-weighted imaging (SWI)
- T1 rho
- MR angiography (and venography)
-
MR spectroscopy (MRS)
- 2-hydroxyglutarate peak: resonates at 2.25 ppm
- alanine peak: resonates at 1.48 ppm
- choline peak: resonates at 3.2 ppm
- citrate peak: resonates at 2.6 ppm
- creatine peak: resonates at 3.0 ppm
- functional MRI (fMRI)
- gamma-aminobutyric acid (GABA) peak: resonates at 2.2-2.4 ppm
- glutamine-glutamate peak: resonates at 2.2-2.4 ppm
- Hunter's angle
- lactate peak: resonates at 1.3 ppm
- lipids peak: resonates at 1.3 ppm
- myoinositol peak: resonates at 3.5 ppm
- MR fingerprinting
- N-acetylaspartate (NAA) peak: resonates at 2.0 ppm
- propylene glycol peak: resonates at 1.13 ppm
-
MRI artifacts
- MRI hardware and room shielding
- MRI software
- patient and physiologic motion
- tissue heterogeneity and foreign bodies
- Fourier transform and Nyquist sampling theorem
- MRI contrast agents
- MRI safety
-
ultrasound
- ultrasound physics
-
transducers
- linear array
- convex array
- phased array
- frame averaging (frame persistence)
- ultrasound image resolution
- imaging modes and display
- pulse-echo imaging
- real-time imaging
-
Doppler imaging
- Doppler effect
- color Doppler
- power Doppler
- B flow
- color box
- Doppler angle
- pulse repetition frequency and scale
- wall filter
- color write priority
- packet size (dwell time)
- peak systolic velocity
- end-diastolic velocity
- resistive index
- pulsatility index
- Reynolds number
- panoramic imaging
- compound imaging
- harmonic imaging
- elastography
- scanning modes
- 2D ultrasound
- 3D ultrasound
- 4D ultrasound
- M-mode
-
ultrasound artifacts
- acoustic shadowing
- acoustic enhancement
- beam width artifact
- reverberation artifact
- ring down artifact
- mirror image artifact
- side lobe artifact
- speckle artifact
- speed displacement artifact
- refraction artifact
- multipath artifact
- anisotropy
- electrical interference artifact
- hardware-related artifacts
- Doppler artifacts
- aliasing
- tissue vibration
- spectral broadening
- blooming
- motion (flash) artifact
- twinkling artifact
- acoustic streaming
- biological effects of ultrasound
- history of ultrasound
-
nuclear medicine
- nuclear medicine physics
- detectors
- tissue to background ratio
-
radiopharmaceuticals
- fundamentals of radiopharmaceuticals
- radiopharmaceutical labeling
- radiopharmaceutical production
- nuclear reactor produced radionuclides
- cyclotron produced radionuclides
- radiation detection
- dosimetry
- specific agents
- carbon-11
- chromium-51
- fluorine agents
- gallium agents
- Ga-67 citrate
- Ga-68
- iodine agents
-
I-123
- I-123 iodide
- I-123 ioflupane (DaTSCAN)
- I-123 ortho-iodohippurate
- I-131
-
MIBG scans
- I-123 MIBG
- I-131 MIBG
-
I-123
- indium agents
- In-111 Octreoscan
- In-111 OncoScint
- In-111 Prostascint
- In-111 oxine labeled WBC
- krypton-81m
- nitrogen-13
- oxygen-15
- phosphorus-32
- selenium-75
-
technetium agents
- Tc-99m DMSA
- Tc-99m DTPA
- Tc-99m DTPA aerosol
- Tc-99m HMPAO
- Tc-99m HMPAO labeled WBC
- Tc-99m MAA
- Tc-99m MAG3
- Tc-99m MDP
- Tc-99m mercaptoacetyltriglycine
- Tc-99m pertechnetate
- Tc-99m labeled RBC
- Tc-99m sestamibi
- Tc-99m sulfur colloid
- Tc-99m sulfur colloid (oral)
- thallium-201 chloride
- xenon agents
- in vivo therapeutic agents
- pharmaceuticals used in nuclear medicine
-
emerging methods in medical imaging
- radiography
- phase-contrast imaging
- CT
- deep-learning reconstruction
- photon counting CT
- virtual non-contrast imaging
- ultrasound
- magnetomotive ultrasound (MMUS)
- superb microvascular imaging
- ultrafast Doppler imaging
- ultrasound localization microscopy
- MRI
- nuclear medicine
- total body PET system
- immuno-PET
- miscellaneous
- radiography